147 related articles for article (PubMed ID: 26111023)
1. Discovery of a latent calcineurin inhibitory peptide from its autoinhibitory domain by docking, dynamic simulation, and in vitro methods.
Harish BM; Saraswathi R; Vinod D; Devaraju KS
J Biomol Struct Dyn; 2016 May; 34(5):983-92. PubMed ID: 26111023
[TBL] [Abstract][Full Text] [Related]
2. The secondary structure of calcineurin regulatory region and conformational change induced by calcium/calmodulin binding.
Shen X; Li H; Ou Y; Tao W; Dong A; Kong J; Ji C; Yu S
J Biol Chem; 2008 Apr; 283(17):11407-13. PubMed ID: 18296442
[TBL] [Abstract][Full Text] [Related]
3. Peptides derived from transcription factor EB bind to calcineurin at a similar region as the NFAT-type motif.
Song R; Li J; Zhang J; Wang L; Tong L; Wang P; Yang H; Wei Q; Cai H; Luo J
Biochimie; 2017 Nov; 142():158-167. PubMed ID: 28890387
[TBL] [Abstract][Full Text] [Related]
4. The regulatory domains of CNA have different effects on the inhibition of CN activity by FK506 and CsA.
Wang HL; Du YW; Xiang BQ; Lin WL; Wei Q
IUBMB Life; 2007 Jun; 59(6):388-93. PubMed ID: 17613169
[TBL] [Abstract][Full Text] [Related]
5. Cooperative autoinhibition and multi-level activation mechanisms of calcineurin.
Li SJ; Wang J; Ma L; Lu C; Wang J; Wu JW; Wang ZX
Cell Res; 2016 Mar; 26(3):336-49. PubMed ID: 26794871
[TBL] [Abstract][Full Text] [Related]
6. Different roles of Loop 7 in inhibition of calcineurin.
Wang H; Yao S; Lin W; Du Y; Xiang B; He S; Huang C; Wei Q
Biochem Biophys Res Commun; 2007 Oct; 362(2):263-8. PubMed ID: 17707777
[TBL] [Abstract][Full Text] [Related]
7. A fragment-based docking simulation for investigating peptide-protein bindings.
Liao JM; Wang YT; Lin CS
Phys Chem Chem Phys; 2017 Apr; 19(16):10436-10442. PubMed ID: 28379224
[TBL] [Abstract][Full Text] [Related]
8. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
John A; Vetrivel U; Subramanian K; Deepa PR
J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
[TBL] [Abstract][Full Text] [Related]
9. A renewed model of CNA regulation involving its C-terminal regulatory domain and CaM.
Wang H; Du Y; Xiang B; Lin W; Li X; Wei Q
Biochemistry; 2008 Apr; 47(15):4461-8. PubMed ID: 18348537
[TBL] [Abstract][Full Text] [Related]
10. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
11. Studies on the interactions of kaempferol to calcineurin by spectroscopic methods and docking.
Lei H; Qi Y; Jia ZG; Lin WL; Wei Q
Biochim Biophys Acta; 2009 Aug; 1794(8):1269-75. PubMed ID: 19439201
[TBL] [Abstract][Full Text] [Related]
12. In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS).
Kant V; Vijayakumar S; Sahoo GC; Ali V; Singh K; Chaudhery SS; Das P
J Biomol Struct Dyn; 2019 Feb; 37(2):481-492. PubMed ID: 29415627
[TBL] [Abstract][Full Text] [Related]
13. Hit-to-Lead Short Peptides against Dengue Type 2 Envelope Protein: Computational and Experimental Investigations.
Zaidi NJ; Abdullah AA; Heh CH; Lin CH; Othman R; Ahmad Fuaad AAH
Molecules; 2022 May; 27(10):. PubMed ID: 35630712
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic and thermodynamic analysis of calcineurin inhibition by RCAN1.
Ma Y; Jiang G; Wang Q; Sun Y; Zhao Y; Tong L; Luo J
Int J Biol Macromol; 2015 Jan; 72():254-60. PubMed ID: 25193101
[TBL] [Abstract][Full Text] [Related]
15. An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors.
Xie H; Li Y; Yu F; Xie X; Qiu K; Fu J
Int J Mol Sci; 2015 Nov; 16(11):27350-61. PubMed ID: 26580609
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of calcineurin activation by calmodulin.
Ye Q; Feng Y; Yin Y; Faucher F; Currie MA; Rahman MN; Jin J; Li S; Wei Q; Jia Z
Cell Signal; 2013 Dec; 25(12):2661-7. PubMed ID: 24018048
[TBL] [Abstract][Full Text] [Related]
17. NMR resonance assignments of the catalytic domain of human serine/threonine phosphatase calcineurin in unligated and PVIVIT-peptide-bound states.
Takeuchi K; Sun ZY; Li S; Gal M; Wagner G
Biomol NMR Assign; 2015 Apr; 9(1):201-5. PubMed ID: 25209144
[TBL] [Abstract][Full Text] [Related]
18. Interaction of glycyrol with calcineurin A studied by spectroscopic methods and docking.
Peng L; Qi Y; Wu H; Wei Q
IUBMB Life; 2011 Jan; 63(1):14-20. PubMed ID: 21280172
[TBL] [Abstract][Full Text] [Related]
19. The polarity of the amino acid residue 118 of calcineurin B is closely linked to calcineurin enzyme activity.
Chen Q; Wu W; Li J; Wei Q
IUBMB Life; 2010 Jul; 62(7):561-7. PubMed ID: 20552635
[TBL] [Abstract][Full Text] [Related]
20. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
Wang P; Li Y; Shao Q; Zhou W; Wang K
J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
